Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Biochemical and Biophysical Methods|January 25, 2003
Enantiomeric separation of substituted 2-arylindoles on derivatised polysaccharide chiral stationary phasesAlan P Watt, Laure Hitzel, Russell J Mortishire-Smith
Current Opinion in Drug Discovery & Development|March 5, 2003
Metabolite identification in drug discoveryAlan P Watt, Russell J Mortishire-Smith, Ute Gerhard, et al.
Chemical Research in Toxicology|January 20, 2004
Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and developmentDavid C Evans, Alan P Watt, Deborah A Nicoll-Griffith, et al.
Analytical Biochemistry|February 14, 2006
A quantitative high-throughput trapping assay as a measurement of potential for bioactivationGeorgina Meneses-Lorente, Melanie Zea Sakatis, Timothy Schulz-Utermoehl, et al.
Obesity (Silver Spring, Md.)|April 30, 2025
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity modelPeter Thornton, Valérie Reader, Zsofia Digby, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 2006
Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 inductionGeorgina Meneses-Lorente, Christine Pattison, Claire Guyomard, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 9, 2024
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796Peter Thornton, Valérie Reader, Zsofia Digby, et al.
Pageof 3